Cargando…
A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus
BACKGROUND: Thiazolidinediones (TZDs) have been associated with various safety concerns including weight gain, bladder cancer, and congestive heart failure (CHF). This study evaluated the efficacy and safety of lobeglitazone, a novel TZD in patients with type 2 diabetes mellitus (T2DM) in real pract...
Autores principales: | Kim, Bo-Yeon, Kwon, Hyuk-Sang, Kim, Suk Kyeong, Noh, Jung-Hyun, Park, Cheol-Young, Park, Hyeong-Kyu, Song, Kee-Ho, Won, Jong Chul, Yu, Jae Myung, Lee, Mi Young, Lee, Jae Hyuk, Lim, Soo, Chun, Sung Wan, Jeong, In-Kyung, Chung, Choon Hee, Han, Seung Jin, Kim, Hee-Seok, Min, Ju-Young, Kim, Sungrae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723193/ https://www.ncbi.nlm.nih.gov/pubmed/35255547 http://dx.doi.org/10.4093/dmj.2021.0264 |
Ejemplares similares
-
Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
por: Kim, Kyung-Soo, et al.
Publicado: (2020) -
Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver
por: Seo, Hye-Young, et al.
Publicado: (2023) -
Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ
por: Jang, Jun Young, et al.
Publicado: (2018) -
Lobeglitazone Attenuates Airway Inflammation and Mucus Hypersecretion in a Murine Model of Ovalbumin-Induced Asthma
por: Shin, Na-Rae, et al.
Publicado: (2018) -
Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
por: Bae, Jaehyun, et al.
Publicado: (2021)